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 1 
PRE-PARTUM IGF1 LEVEL PREDICT KETOSIS 1 
Piechotta 2 
The uncoupling of the somatotropic axis is one of the key metabolic adaption pathways 3 
during the transition from late pregnancy to early lactation and is reflected by increasing 4 
growth hormone concentrations and a decreasing hepatic production of IGF1. This study 5 
shows that low total IGF1 concentrations in clinically healthy pluriparous Holstein Friesian 6 
cows in late pregnancy (262 - 270 d after artificial insemination) predicted the risk of clinical 7 
ketosis after calving. The sensitivity was 51 % and the specificity 83 % (threshold IGF1 = 62 8 
ng / mL, and IGF1 may represent an early biomarker of inadequate metabolic adaptation to 9 
the high-energy demand required post partum. 10 
 11 
 12 
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Antepartal IGF1 and IGFBP2 concentrations are indicative of ketosis in dairy cows 16 
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 3 
ABSTRACT 38 
A study involving a small number of cows found that the concentrations of insulin-like 39 
growth hormone-1 (IGF1) may be a useful predictor of metabolic disease. Further, IGF1 may 40 
provide also a pathophysiological link to metabolic diseases such as ketosis. The objective of 41 
the current study was to test whether the low antepartal total IGF1 or IGF1 binding protein 42 
(IGFBP) concentrations might predict ketosis under field conditions. Clinical examinations 43 
and blood sampling were performed ante partum (262-270 d after artificial insemination (AI)) 44 
on 377 pluriparous pregnant Holstein Friesian cows. The presence of postpartum diseases 45 
were recorded (ketosis, fatty liver, displacement of the abomasum, hypocalcemia, mastitis, 46 
retention of fetal membranes, and clinical metritis/endometritis), and the concentrations of 47 
IGF1, IGFBP2, IGFBP3 and non-esterified fatty acids were measured. Cows with post partum 48 
clinical ketosis had lower IGF1 concentrations ante partum than healthy cows. The sensitivity 49 
of antepartal IGF1 as a marker for post partum ketosis was 0.87, and the specificity was 0.43; 50 
a positive predictive value of 0.91 and a negative predictive value of 0.35 were calculated. 51 
The cows with ketosis and retained fetal membranes had lower IGFBP2 concentrations 52 
compared with the healthy cows. It can be speculated that lower IGF1 production in the liver 53 
during late pregnancy may increase growth hormone secretions and lipolysis, thereby 54 
increasing the risk of ketosis. Lower IGFBP2 concentrations may reflect the suppression of 55 
IGFBP2 levels through higher growth hormone secretion. In conclusion, compared with non-56 
esterified fatty acids as a predictive parameter, IGF1 and IGFBP2 may represent earlier 57 
biomarkers of inadequate metabolic adaptation to the high-energy demand required post 58 
partum. 59 
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 64 
INTRODUCTION 65 
 66 
The growth hormone (GH)-IGF axis is an important endocrine control center for metabolic 67 
adaptation in dairy cows. Studies have indicated that IGF1 may be useful as a predictive 68 
marker for postpartum (pp) production diseases (Piechotta et al., 2012) or for successful early 69 
ovulation pp (Kawashima et al., 2007). Moreover, from in-vitro studies, IGF1 is known to be 70 
an important signal for gluconeogenesis (Wang et al., 2012); therefore, a physiological 71 
association between IGF1 and particularly metabolic diseases, such as ketosis, is likely, but 72 
the exact mechanisms between the somatotropic axis and the pathogenesis of ketosis are not 73 
well studied. Studies have attempted to influence the GH-IGF1 axis by administering bovine 74 
somatotropin (bST) antepartum (ap). Although ap bST administration did not affect the 75 
incidence of hyperketonemia, dry matter intake or clinical ketosis (Gohary et al., 2014), a 76 
clear association between low IGF1 concentrations and metabolic production diseases was 77 
evident (Piechotta et al., 2012). Cows that were classified based on low versus high IGF1 78 
levels revealed that there were no differences in the hepatic growth hormone receptor mRNA 79 
expression (Piechotta et al., 2013, 2014), which might explain why the bST administration did 80 
not have an effect on the incidence of ketosis. However, from these studies, it was not clear 81 
which factors might be responsible for the association between low total IGF1 levels and the 82 
incidence of metabolic diseases. Moreover, the number of cattle used in the study was low, 83 
and only IGF1 was measured (Piechotta et al., 2012). However, IGF1 is bound to six different 84 
high affinity IGF binding proteins (IGFBP) that determine the half-life of IGF1 and its 85 
delivery through the endothelium to the target cells. The IGFBP concentration might be one 86 
factor for different total IGF1 concentrations. Therefore, the concentrations of the two most 87 
abundant IGFBPs (IGFBP2 and IGFBP3) were determined in the present study with a greater 88 
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number of animals under field conditions to clarify whether ap total IGF1 or IGFBP 89 
concentrations might predict the risk of ketosis or other pp production diseases. 90 
 91 
MATERIALS AND METHODS 92 
Animals 93 
In one large-scale dairy farm ( ~ 1300 cows) in eastern Germany (Göritz, Brandenburg), 377 94 
pluriparous Holstein Friesian cows in late pregnancy (2
nd
 to 4
th
 lactation, 305-day milk yield 95 
of 11,200 ± 97 kg [mean ± SEM]) were examined, and blood samples were obtained. The 96 
experimental procedure was approved by the German legislation responsible for animal 97 
welfare (Landesamt für Umwelt, Gesundheit und Verbraucherschutz, Abteilung 98 
Verbraucherschutz in Frankfurt (Oder); 23-2347-A19-3-2010). The cows were housed during 99 
all seasons in a free-stall barn with rubber mats and were fed automatically by a band-100 
conveyor system twice daily with a total mixed ration depending on the lactation period 101 
(Table 1, 2). The cows were provided with a mineral supply (Deutsche Vilomix 102 
Tierernährung GmbH, Neuenkirchen-Vörden, Germany), and they had free access to water. 103 
The cows were kept in groups depending on the lactation interval (early [50 days pp], mid, 104 
late, and dried-off). The cows were dried-off approximately six weeks before the expected 105 
calving date. Approximately ten days before calving, the cows were placed in a free-stall barn 106 
with straw bedding in which the cows were monitored for signs of birth every two hours by 107 
the farm staff. The cows were milked three times daily, and the milk yields were recorded 108 
once a month by the routine control office (Landeskontrollverband Brandenburg, 109 
Brandenburg, Germany). 110 
 111 
Monitoring of Health Status and Blood Sampling 112 
The cows were monitored daily by the farm staff via observing the feed intake ap and pp and 113 
recording milk yield, milk character and the udder after calving. If the cows showed either a 114 
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reduction in feed intake and/or milk yield, a farm veterinarian was summoned, and the cows 115 
were diagnosed and treated. Moreover, the cows were examined clinically by a study 116 
veterinarian once ap between 262-270 d after artificial insemination (AI) and two times pp at 117 
three ( + 3 wk: 16 – 21 d pp) and four weeks ( + 4 wk: 22 – 28 d pp) after calving. At each 118 
examination, behavior, posture, body temperature and BCS were recorded (Edmonson et al., 119 
1989). Additionally, the milk yield during the previous lactation was documented. A 120 
gynecological examination was performed to assess the occurrence of metritis/endometritis in 121 
accordance with Sheldon et al. (2008). After each examination, a blood sample was obtained 122 
from a coccygeal vessel directly into tubes with EDTA and without any anticoagulants to 123 
acquire serum (Sarstedt, Nümbrecht, Germany). The EDTA containing the samples was kept 124 
on ice, whereas the serum samples were kept until clotting at ~ 20 ° C. After centrifugation 125 
(2000 g, 15 min, 4 ° C, Hettich EBA 20, Germany), which occurred within two hours after 126 
sampling, the samples were kept at – 20 ° C until further analyses. Moreover, if a decrease in 127 
the milk yield or feed intake of the cows was detected by the farm stuff, the farm veterinarian 128 
conducted a clinical examination and recorded the diagnosis according to the stated 129 
definitions provided below. The day of AI and the calving date were recorded using the farm 130 
management software (“HERDE2”, dsp-agrosoft, Paretz, Germany). A variety of pp diseases 131 
were identified, and the cows were defined as ill if such an illness was recorded once. 132 
Metabolic diseases, such as ketosis, were diagnosed if reductions in feed intake and/or milk 133 
yield occurred and if the urine tested positive for ketone bodies (“Ketostix strip”, Bayer, 134 
Leverkusen, Germany, positive ( + + + )). Displacement of the abomasum was defined when 135 
reductions in feed intake and/or milk yield were observed and abdominal percussion and 136 
auscultation were positive. Cows with the following symptoms were suspected of having 137 
hypocalcemia: precarious motion, cold body surface, ataxia, and downer cow syndrome. 138 
Hypocalcemia was diagnosed if those symptoms disappeared after one infusion of 10 g of 139 
calcium as 25 % calcium borogluconate. Fatty liver syndrome was suspected if the cows had a 140 
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body weight > 800 kg at the time of calving and if the cows had reduced feed intake and/or 141 
displacement of the abomasum. Then, a liver biopsy was conducted, and a flotation test was 142 
performed. If the biopsy floated in 1020 mg / mL of CuSO4 ( = 26 % fat in the liver), fatty 143 
liver syndrome was defined (Herdt et al., 1983). A mastitis was diagnosed when the milk 144 
showed compositional changes, the udder had signs of inflammation, and the veterinarian 145 
detected an elevated cell count in the milk using the California Mastitis Test (CMT + + + , 146 
WDT, Garbsen, Germany) according to Sargeant et al., 2001 ( > 100,000 cells / mL). The 147 
retention of fetal membranes (RMF) was defined if fetal membranes were still evident 12 h 148 
after calving. Uterine content and vaginal discharge before or after twenty-one days of calving 149 
indicated metritis/endometritis (Sheldon et al., 2008), which were combined as “metritis” for 150 
the statistical analyses. 151 
 152 
Endocrine Analyses 153 
IGF1. The total plasma IGF1 concentrations were determined using a commercial IGF1-154 
ELISA kit (Active IGF1 ELISA; Beckman Coulter, CA, USA) with standard operations 155 
according to the manual. The optical density was measured (450 nm), and the concentrations 156 
were calculated with Magellan software using the cubic spline modus (Magellan 3.11, 157 
Dortmund, Germany). The range of measurements was 10 to 450 ng / mL. The analytical 158 
sensitivity was 0.03 ng / mL. The intra- and inter-assay CVs were 3.5 and 8.5 %, respectively. 159 
 160 
Quantitative Western Blotting for IGFBP2 and IGFBP3. To analyze the concentrations of 161 
serum IGFBP2 and IGFBP3 via the binding capacities, a quantitative Western ligand blotting 162 
analysis of the serum was performed as previously described (Metzger et al., 2011). Briefly, 163 
before electrophoresis on a 5 % stacking / 12 % separating SDS-polyacrylamide gel, the serum 164 
samples were diluted 1 : 3 with phosphate buffer (pH 7.4), diluted again 1 : 2 with sample buffer 165 
[62.5 mM Tris-HCl (pH 6.8), 2 % (w/v) sodium dodecyl sulfate (SDS), and 10 % (w/v) sucrose], 166 
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and boiled (5 min). The separated proteins were transferred to a polyvinyl fluoride membrane 167 
(Millipore, Schwalbach, Germany). The blots were blocked using 1 % fish gelatin and incubated 168 
with [
125
I] IGF1. Using recombinant human IGFBP2 and IGFBP3 as internal standards on 169 
each blot, the IGFBPs were quantified on a Phosphor-Imager Storm (Molecular Dynamics, 170 
CA, USA). The intra-assay variances for the IGFBP2 and -3 determinations in bovine serum 171 
were less than 10%. The inter-assay variances ranged between 15 - 20 % , which is acceptable 172 
for Western blot based technologies. The lower limits of quantification in the bovine serum 173 
were 0.2 ng for IGFBP2 and 1.1 ng for IGFBP3. 174 
 175 
Nonesterified Fatty Acids. The serum concentrations of NEFAs were measured using a 176 
photometric automatic clinical chemistry analyzer (ABX Pentra 400, Horiba, Montpellier, 177 
France) by using the NEFA - HR2 Olympus AU 400 Kit (mti-diagnostics GmbH, Idstein, 178 
Germany) .  The intra-assay CV was 6.2 % .  179 
 180 
Statistics 181 
The statistical evaluation of the blood data was performed using SPSS (Version 17.0., SPSS 182 
Inc., Chicago, IL, USA). All the data (IGF1, IGFBP2 and -3, and NEFA) were tested for 183 
normal distributions using the Kolmogorow-Smirnow test, as modified by Lilliefors (1967), 184 
and by a visual inspection of the histograms. The BCS and IGF1 concentrations were tested 185 
for differences between the three sampling periods using Student’s t-test. Health status was 186 
tested for significant differences using Fisher’s exact test or a chi-square test. A relative risk 187 
assessment was performed to evaluate the potential uses of IGF1, IGFBP2 and NEFA as risk 188 
markers for pp diseases. A logistic regression model was developed (odds ratio), and a 189 
receiver operating characteristics (ROC) curve was constructed to determine the highest 190 
possible sensitivity and specificity. The Youden-Index was calculated using the following 191 
 9 
formula: sensitivity + specificity - 1. A P-value of < 0.05 was considered significant, and a P-192 
value between 0.05 and ≤ 0.10 was classified as a statistical tendency.  193 
RESULTS 194 
 195 
Diseases  196 
A total of 189 (50.1 % ) cows developed production diseases pp, whereas 188 cows (49.9 % ) 197 
remained healthy during the transition from late pregnancy to early lactation. Of the diseased 198 
cows, 73 (34 % ) had metabolic diseases, and 142 (66 % ) had diseases of the reproductive 199 
system (Table 3). 200 
 201 
Body Conditioning Score and Milk Yield 202 
The BCS of the cows was 4.3 ± 0.03 before calving and decreased pp ( + 3 wk: 3.2 ± 0.03; 203 
and + 4 wk: 3.1 ± 0.03; P < 0.01). The mean BCS remained constant between 3 and 4 weeks 204 
pp ( P = 0.13). Calving occurred at 281 ± 5 days after AI. The mean ap BCS of the healthy 205 
cows was comparable to the cows that developed any production disease after calving (4.30 ± 206 
0.04 vs. 4.22 ± 0.05; P = 0.21). In the cows that developed fatty liver disease after calving (n 207 
= 5), the BCS was ap higher (4.90 ± 0.10; P < 0.01) compared with the healthy cows. The 208 
mean milk yield in the previous lactation of the healthy cows was comparable to that in the 209 
cows that developed any production disease after calving (11,279.3 ± 131.1 vs. 11,145.3 ± 210 
145.2 kg; P = 0.49). No significant association between the previous milk yield and the 211 
occurrence of any pp production disease was found.  212 
 213 
Insulin-like Growth Factor 1 214 
In total, the IGF1-concentrations of all the cows ap were higher (88.6 ± 1.5 ng / mL; P < 0.01) 215 
compared with pp + 3 wk (50.4 ± 1.4 ng / mL) and + 4 wk (53.5 ± 1.3 ng / mL). The cows 216 
with a greater loss in BCS between ap and + 3 wk (BCS loss > 1, n = 213) compared with the 217 
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cows with a smaller BCS loss (BCS loss ≤ 1, n = 164) showed comparable IGF1 218 
concentrations before calving (90.2 ± 4.8 vs. 91.5 ± 4.0 ng / mL, respectively, P = 0.68) but 219 
had lower IGF1 concentrations at + 3 wk (44.9 ± 1.8 vs. 55.7 ± 2.1 ng / mL, respectively, P < 220 
0.01) and at + 4 wk (48.1 ± 3.5 vs. 57.4 ± 3.6 ng / mL, respectively, P < 0.01) after parturition. 221 
 222 
IGF1 as a predictive marker for postpartum ketosis.  The cows that remained healthy after 223 
parturition had higher IGF1 concentrations ap (91.5 ± 1.9 ng / mL) compared with the cows 224 
that developed production diseases (ap 85.7 ± 2.2 ng / mL) (P = 0.05). However, after 225 
parturition, the healthy cows had similar IGF1 levels ( + 3 wk, 51.0 ± 1.9 ng/mL; + 4 wk, 53.9 226 
± 1.8 ng / mL) compared to the cows that developed production diseases ( + 3 wk, 49.7 ± 2.2 227 
ng / mL; + 4 wk, 52.9 ± 1.9 ng / mL) (P = 0.64 and P = 0.70). The cows with pp clinical 228 
ketosis had lower IGF1 concentrations ap than the cows that remained healthy after 229 
parturition (P < 0.01). The IGF1 concentrations of the cows with other diseases were 230 
comparable to the concentrations in the healthy cows (Figure 1, P > 0.05).  The ROC-analysis 231 
revealed a significant association between IGF1 and ketosis (P < 0.01), the sensitivity of the 232 
ap IGF1 concentration as a marker for pp ketosis was 0.87, the specificity was 0.43, the 233 
positive predictive value (PPV) was 0.91 and the negative predictive value (NPV) was 0.35. 234 
The threshold for distinguishing healthy cows from cows with clinical ketosis was 61.7 ng / 235 
mL (Youden-Index = 0.31). The maximal Youden - Index was 0.45 and was found at a cutoff 236 
= 90.2 ng / mL; with a sensitivity of 0.51, a specificity of 0.83, a PPV of 0.95 and a NPV of 237 
0.21, the AUC was 0.7305 (Figure 2). The cows with 10 ng / mL or higher ap IGF1-238 
concentrations had a 37 % reduced risk for developing clinical ketosis within the first 4 weeks 239 
after parturition (OR = 0.97). 240 
 241 
Insulin-like Growth Factor Binding Proteins 242 
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The cows with ketosis and with RFM had significantly lower IGFBP2 concentrations 243 
compared with the healthy cows (Figure 3, P < 0.01). The ROC analysis revealed a significant 244 
association between IGFBP2 and ketosis (P = 0.01), a maximal Youden-Index of 0.37 at a 245 
cutoff of IGFBP2 = 3.5 ng/µl with a sensitivity of 0.70 and a specificity of 0.67. The PPV was 246 
0.93 and the NPV was 0.22, corresponding to an AUC of 0.6625. The IGFBP3 concentrations 247 
ap were comparable between the healthy cows and the cows that developed any production 248 
disease (Figure 4).  249 
 250 
Nonesterified fatty acids 251 
The NEFA concentrations before calving were comparable between the healthy cows and the 252 
cows that developed a production disease pp (Figure 5, P > 0.05). The ROC analyses revealed 253 
no significant association between ap NEFA and pp clinical ketosis (P = 0.07), a maximal 254 
Youden-Index of 0.17 at a cutoff of NEFA = 158 µmol/L with a sensitivity of 0.80 and a 255 
specificity of 0.37. The PPV was 0.88 and the NPV was 0.22, corresponding to an AUC of 256 
0.5832. 257 
 258 
 259 
DISCUSSION 260 
 261 
This study aimed to determine whether IGF1 and IGFBPs were ap risk biomakers for pp 262 
diseases in dairy cows under field conditions. It is well known that the transition from late 263 
pregnancy to early lactation is a critical time period with the occurrence of many orchestrated 264 
and interacting endocrine adaptations. If these adaptations are inadequate, the dairy cow is 265 
susceptible to metabolic and infectious diseases after calving (Chagas et al., 2007; Williams, 266 
2013; Roche et al., 2013; Lean et al., 2013). In a previous study, it appeared that hepatic 267 
derived IGF1 might serve as a promising indicative marker for pp ketosis (Piechotta et al., 268 
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2012). In this study, IGF1 was significantly lower between 242 - 262 days after AI in cows 269 
that developed a production disease after calving. Detailed studies on the differences between 270 
cows selected for either low or high ap IGF1 levels have revealed that NEFA concentrations 271 
increased after the IGF1 concentration was already very low (Piechotta et al., 2013, 2014). 272 
Elevated GH in catabolic conditions also has a lipolytic potential combined with 273 
catecholamines and low insulin levels and may thus be related to increased NEFA values 274 
(Rose et al., 2009; Lanna and Bauman, 1999; Houseknecht and Bauman, 1997). Furthermore, 275 
decreased IGF1 concentrations increase the GH release because of a reduced negative 276 
feedback at the pituitary level (Hannon et al., 1991; Kobayashi et al., 1999; Lucy et al., 2001). 277 
Because of this regulation, IGF1 may be more effective as a very early risk indicator for pp 278 
ketosis compared with NEFA or BHBA concentrations. The IGF1 concentrations in the 279 
present study were significantly lower in the cows that developed clinical pp ketosis 280 
compared to the healthy cows or the cows with other production diseases. Additionally, the 281 
NEFA concentrations were not significantly different at this early period of sampling (days 282 
262 - 270 after AI); however, the standard deviation of the NEFA concentrations was higher 283 
in this group than in the other groups. This result may indicate that the initiation of lipolysis 284 
and the increased NEFA values were a result of lower IGF1 levels; therefore, IGF1 serum 285 
levels may be useful for the identification of cows at risk for ketosis as early as possible. A 286 
low BCS after calving was associated with a higher risk for ketosis during early lactation 287 
(Koeck et al., 2014). In the present study, the ante partum BCS was comparable between the 288 
healthy cows and the cows that developed ketosis. Notably, the BCS of the cows in the 289 
present study was high, which could be a confounding variable.  290 
 291 
The measured IGF1 was defined as the total IGF1, which included all IGF1 molecules free or 292 
bound to their IGFBPs. In the circulation, the main binding protein is IGFBP3, which 293 
complexes IGF1 with the acid labile subunit and primarily increases the half-life (Rajaram et 294 
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al., 1997; Nedbal et al., 2000). Notably, the IGFBP3 concentration did not correlate with total 295 
IGF1 and was comparable between the healthy cows and the cows with pp diseases. It must 296 
be noted that the IGFBPs were determined using a Western blot with a high intra-assay 297 
CV % , which might be responsible for this not significant correlation. Piechotta et al. (2013) 298 
found that IGFBP3 concentrations decreased towards calving and that cows with low IGF1 299 
concentrations did not have significantly lower IGFBP3 serum concentrations in late 300 
pregnancy. Feed restrictions can cause lower IGF1 and IGFBP3 concentrations pp, as was 301 
demonstrated by Gross et al. (2011), but in other studies, no significant differences between 302 
IGF1 and IGFBP3 concentrations with respect to feed restrictions were detected (Laeger et al., 303 
2014). With this respect, factors other than feed intake may regulate hepatic IGF1 production 304 
and IGFBP3 concentrations in the blood. One possibility for the absence of a correlation 305 
between total IGF1 and IGFBP3 could be that proteases caused a cleavage of IGFBP3 in late 306 
pregnancy, as has been described in rats (Wu et al.1999; Fowlkes et al., 1994). Even if human 307 
recombinant standards were used for the quantification of bovine IGFBPs, a method 308 
dependent reason for the difference between IGF1 and IGFBP3 concentrations is not obvious. 309 
This assumption is supported by the high sequence homologies present in the terminal protein 310 
domains from IGFBPs of different vertebrate species. Piechotta et al. (2013) published RIA 311 
data for IGFBP2 in serum from cattle using a validated assay and obtained concentrations 312 
ranging between 0.5 to 2.5 µg / mL; these findings were consistent with Cohick et al. (1992) 313 
and Renaville et al. (2000). The IGFBP3 values that were obtained by the Western blot 314 
technique were also comparable to published data generated by an ELISA specific for bovine 315 
IGFBP3 that ranged between 1 - 3 µg / mL (Hennies and Sauerwein, 2003). This comparison 316 
shows that the values were similar even when measured by different techniques. This result 317 
may additionally underpin the validity of the method used.  318 
Notably, in cows with fatty liver disease, the standard deviations of the IGF1, IGFBP3 and 319 
NEFA concentrations were high, which may indicate a difference in the severity of hepatic fat 320 
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accumulation reflected by peripheral metabolites. A greater fat content in the liver has also 321 
previously been shown to be correlated with greater fat mobilization (Hammon et al., 2009), 322 
which may substantiate this speculation. A more detailed differentiation of the fatty liver 323 
syndrome would have been of interest, but that was not addressed in the present study.  324 
 325 
For a screening test of pp ketosis, a high sensitivity is required. The ROC analyses revealed a 326 
threshold of 62 ng / mL for IGF1 with a sensitivity of 0.87 and a specificity of 0.43 and a 327 
maximal Youden-Index of 0.31 (cutoff = 90 ng / mL; sensitivity of 0.51 and specificity of 328 
0.83). Therefore, depending on the threshold used, either a higher sensitivity or specificity can 329 
be chosen for a potential screening test. However, differences among assays and laboratories 330 
suggest that IGF1 concentrations in the blood must be evaluated for a specific laboratory and 331 
test method. The assay results for the IGF1 tests indicating a sensitivity of 0.51, a specificity 332 
of 0.83 and a Youden-Index of 0.31 appear to be superior to those of NEFA in this study in 333 
predicting the risk of ketosis after calving, given the Youden-Index of 0.17 with a sensitivity 334 
of 0.80 and a specificity of 0.37. It is notable that whereas IGF1 was less sensitive, it was 335 
more specific and had a higher total Youden-Index and a higher area under the curve than the 336 
NEFA values. Although ap NEFA and pp BHBA concentrations were both associated with 337 
the development of clinical disease, pp serum NEFA concentrations were the most associated 338 
with the risk of developing clinical ketosis ( Lean et al., 1994; Ospina et al., 2010). However, 339 
a closer look at sensitivity and specificity clearly showed that the IGF1 concentrations 340 
determined in the present study had a higher specificity and sensitivity than did the NEFA 341 
concentrations and could be measured earlier prior to calving. A NEFA concentration 342 
measured 14 days before calving had a sensitivity of 0.53 and a specificity of 0.61 for pp 343 
clinical ketosis, whereas BHBA had a sensitivity of 0.57 and a specificity of 0.8 after calving 344 
(Ospina et al., 2010). In a study by Chapinal et al. (2011), NEFA concentrations obtained one 345 
week before calving were associated with an increased risk of RFM, metritis and LDA but not 346 
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with clinical ketosis (Chapinal et al., 2011). In other studies, the NEFA concentrations 10 347 
days before calving indicated a risk for displaced abomasum and BHBA (subclinical ketosis), 348 
and in the week after parturition, they indicated a risk for clinical ketosis (LeBlanc, 2010). An 349 
extensive evaluation of three different BHBA measuring methods in either milk or urine 350 
revealed a high specificity (0.97 and 0.99) for diagnosing ketosis, whereas the sensitivity for 351 
the diagnosis was lower (0.55 - 0.98). These data also demonstrate that a sensitivity of 0.9 and 352 
a specificity of 0.4 are adequate for predicting ketosis in healthy cows ante partum weeks 353 
before clinical symptoms occur. Overall, the data of the present study clearly indicate that 354 
IGF1 and IGFBP2 are more accurate and serve as earlier risk indicators for ketosis in cows. 355 
Early measurement can lead to appropriate management conditions or feeding additives to 356 
assist cows during the transition from late pregnancy to early lactation and to prevent ketosis.  357 
 358 
Notably, the ap IGFBP2 concentrations were lower in the cows with pp clinical ketosis and 359 
RFM; again, a high standard deviation in the fatty liver group was obvious. In contrast to the 360 
decrease in IGF1 and IGFBP3, the blood concentrations of IGFBP2, the second most 361 
abundant binding protein, increased after parturition (Fenwick et al., 2008; Piechotta et al., 362 
2013; Vicini et al., 1991). The IGFBP2 level was shown to be affected by feed restrictions 363 
three weeks after parturition in dairy cows (Gross et al., 2011) but not during mid-lactation 364 
(Laeger et al., 2014), which indicated that different regulations were operating as calving 365 
approached. In a previous study, hepatic IGFBP2 mRNA expression pp was positively 366 
correlated with NEFA and BHBA and negatively correlated with hepatic glycogen, blood 367 
glucose and IGF1 (Fenwick et al., 2008). However, there appeared to be an early ap signal for 368 
IGFBP2 production. In humans, IGFBP2 was shown to affect insulin resistance and played a 369 
role in metabolic homeostasis (Ruan and Lai, 2010; Wheatcroft and Kearney, 2009). It is well 370 
known that IGFBP2 is suppressed by GH (Hoeflich et al., 2014). Thus, lower IGFBP2 serum 371 
levels found in ketosis may be indicative of the increased GH-secretion discussed earlier and 372 
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thus nicely support our hypothesis. However, the specific functions of this binding protein 373 
regarding metabolic adaptations have not yet been elucidated in cattle. Our data support that 374 
monitoring IGFBPs, particularly IGFBP2, might reflect the GH status or even be useful as 375 
early biomarkers of distinct health conditions or abnormalities. Supposedly a key metabolic 376 
signaling molecule that interacts between metabolism and fertility (Wathes, 2012), this 377 
binding protein was indicative of RFM in the present study. Because it has also been shown 378 
that cows with higher genetic fertility had a higher hepatic expression of IGFBP2 (Cummins 379 
et al., 2012), further studies on the factors affecting this binding protein appear to be 380 
promising.  381 
 382 
CONCLUSIONS 383 
In conclusion, IGF1 and IGFBP2 levels measured ap between 262 - 270 days after AI were 384 
indicative of pp clinical ketosis. Lower IGF1 production in the liver might lead to higher GH 385 
secretion, which can initiate lipolysis and result in increasing NEFA concentrations, which 386 
may consecutively increase the risk of ketosis. Therefore, compared with NEFA or BHBA, 387 
IGF1 and IGFBP2 may represent earlier biomarkers of inadequate metabolic adaptation to the 388 
high-energy demands required pp. To use IGF1 concentrations in the blood as a diagnostic 389 
test, the threshold must be evaluated for a specific laboratory and test method.  390 
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Figure Captions 539 
Figure  1. Antepartal (262 - 270 days after AI) insulin-like growth factor 1 (IGF1) 540 
concentrations (mean ± SD) of the healthy cows and the cows that developed any postpartal 541 
production disease (28 days after calving). * Indicates significant differences (P < 0.05) 542 
between the healthy cows and the cows with any production disease. 543 
 544 
Figure 2. Receiver operating characteristic (ROC) curve for the insulin-like growth factor 1 545 
(IGF1) concentrations in the cows with postpartum ketosis. The two circles indicate the 546 
following thresholds: IGF1: 90.2 ng / mL; sensitivity: 0.51; specificity: 0.83; PPV: 0.95; 547 
NPV: 0.21; and IGF1: 61.7 ng / mL; sensitivity: 0.87; specificity: 0.43; PPV: 0.91; NPV: 548 
0.35.  549 
 550 
Figure  3. Antepartal (262 - 270 days after AI) IGFBP2 concentrations of the healthy 551 
cows and the cows that developed a postpartal production disease (28 days after calving). * 552 
Indicates significant differences with regard to the healthy cows (P < 0.05). 553 
 554 
Figure  4. Antepartal (262 - 270 days after AI) IGFBP3 concentrations of the healthy 555 
cows and the cows that developed a postpartal production disease (28 days after calving). * 556 
Indicates significant differences (P < 0.05) between the healthy cows and the cows with any 557 
production disease. 558 
 559 
Figure 5. Antepartal (262 - 270 days after AI) nonesterified fatty acid (NEFA) concentrations 560 
of the healthy cows and the cows that developed a postpartal production disease (28 days after 561 
calving). * Indicates significant differences with regard to the healthy cows (P < 0.05). 562 
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Figure 1 564 
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Figure 4 573 
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Figure 5 576 
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Table descriptions 580 
Tabel 1. Ingredients of the total mixed rations fed with regard to the different lactation periods. 581 
 582 
Table 2. Chemical composition of the total mixed rations fed with regard to the different 583 
lactation periods 584 
 585 
Table 3. Absolute and relative numbers of cows (percentage of diseased cows out of all tested 586 
cows [n = 377]) with any production disease within the first four weeks after calving. 587 
  588 
 32 
Table 1.  589 
kg DM 
Dry-off ration Fresh cow ration  
wk 6 - 2 ap wk 2 - 0 ap >   day 1 pp  
Grass silage   10.4 2.4 5.2  
Corn silage 1.3 6.6 8.1  
Sugar beet pulp - - 3.6  
Rye straw 0.3 - -  
Wheat 0.4 - 0.6  
Straw 2.4 - 0.5  
Glycerin
1
  - - 0.2  
Corn - - 2.3  
Urea
2 
- - 0.03  
Feed-fat
2 
1.7 - 0.4  
Soy pellet
3 
- - 1.7  
Rape expellers
3 
- - 1.2  
Cattle salt
4 
0.03 0.03 0.03  
Rumen protected protein
1
 - - 1.9  
Propylene-glycol
1
 0.2 - 0.2  
Sugar beet chips 0.32 - -  
Flavorful acid salt 0.5 - -  
 33 
1
Dr. Pieper Technologie- u. Produktentwicklung GmbH, Wuthenow, Germany, 
2
 Spezialfutter 590 
Neuruppin, Germany, 
3
Hauptgenossenschaft Nord AG, Kiel, Germany, 
4
Blattin 591 
Mineralfutterwerk Seitschen GmbH &Co KG, Göda, Germany, ap = ante partum, pp = 592 
postpartum. 593 
 594 
 595 
Table 2.  596 
 
Dry-off ration Fresh cow ration  
wk 6 - 2 ap wk 2 - 0 ap >   day 1 pp  
NEL (MJ / kg DM)   5.53 6.39 7.54  
Crude ash (g / kg DM) 93 63 53  
Crude fat (g / kg DM) 36 29 52  
CP (g / kg DM) 134 142 170  
Crude fiber (g / kg DM) 267 193 157  
 597 
Table 3.  598 
 599 
Disease Ketosis DLA Rumen 
atony 
Hypo-
calcemia 
Fatty 
liver  
Metritis Mastitis RFM 
Number 30 20 14 12 5 66 34 19 
Percentage % 7.9 5.3 3.7 3.2 1.3 17.5 9.0 5.0 
DLA = displacement of the left abomasum, RFM = retained fetal membranes 600 
